These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Drug-induced asterixis]. Rittmannsberger H; Leblhuber F Dtsch Med Wochenschr; 1994 Apr; 119(16):585-8. PubMed ID: 8162841 [TBL] [Abstract][Full Text] [Related]
4. Asterixis as a side effect of carbamazepine therapy. Rittmannsberger H; Leblhuber F; Sommer R Klin Wochenschr; 1991 Apr; 69(6):279-81. PubMed ID: 1674759 [TBL] [Abstract][Full Text] [Related]
5. Hyperammonemia in asterixis induced by carbamazepine: two case reports. Ambrosetto G; Riva R; Baruzzi A Acta Neurol Scand; 1984 Mar; 69(3):186-9. PubMed ID: 6720252 [TBL] [Abstract][Full Text] [Related]
6. Adverse behavioral effects in individuals with mental retardation and mood disorders treated with carbamazepine. Friedman DL; Kastner T; Plummer AT; Ruiz MQ; Henning D Am J Ment Retard; 1992 Mar; 96(5):541-6. PubMed ID: 1562312 [TBL] [Abstract][Full Text] [Related]
7. Complete external ophthalmoplegia and asterixis with carbamazepine toxicity. Ng K; Silbert PL; Edis RH Aust N Z J Med; 1991 Dec; 21(6):886-7. PubMed ID: 1818551 [TBL] [Abstract][Full Text] [Related]
8. Serum drug level monitoring in affective disorders. Krska J; Corner DA J Clin Pharm Ther; 1992 Dec; 17(6):357-63. PubMed ID: 1287028 [TBL] [Abstract][Full Text] [Related]
10. Rational polypharmacy in the bipolar affective disorders. Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735 [TBL] [Abstract][Full Text] [Related]
11. [Therapeutic use of carbamazepine for treatment of agitation and affective disorders in geriatric psychiatry patients]. Lemke MR; Stuhlmann W Psychiatr Prax; 1994 Jul; 21(4):147-50. PubMed ID: 7938323 [TBL] [Abstract][Full Text] [Related]
12. [New psychopharmacologic alternatives in treatment of schizophrenia]. Bryois C Schweiz Arch Neurol Psychiatr (1985); 1994; 145(6):19-24. PubMed ID: 7533941 [TBL] [Abstract][Full Text] [Related]
14. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review]. Munch G; Godart N Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720 [TBL] [Abstract][Full Text] [Related]
15. Antiepileptic drugs with mood stabilizing properties and their relation with psychotropic drug use in institutionalized epilepsy patients with intellectual disability. Leunissen CL; de la Parra NM; Tan IY; Rentmeester TW; Vader CI; Veendrick-Meekes MJ; Aldenkamp AP Res Dev Disabil; 2011; 32(6):2660-8. PubMed ID: 21752594 [TBL] [Abstract][Full Text] [Related]
18. [The use of carbamazepine in affective disorders]. Beresewicz M Psychiatr Pol; 1994; 28(4):455-66. PubMed ID: 7972553 [TBL] [Abstract][Full Text] [Related]
19. The action of mood-stabilizers in affective disorders: an integrative view as a challenge. Emrich HM; Dose M; Wolf R Neuropsychobiology; 1993; 27(3):158-62. PubMed ID: 8232832 [TBL] [Abstract][Full Text] [Related]
20. Asterixis (flapping tremors) as an outcome of complex psychotropic drug interaction. Nayak R; Pandurangi A; Bhogale G; Patil N; Chate S J Neuropsychiatry Clin Neurosci; 2012; 24(1):E26-7. PubMed ID: 22450635 [No Abstract] [Full Text] [Related] [Next] [New Search]